Study on relationship between epidermal growth factor and Bcl-2, Bax genetic expression in placenta of fetal growth retardation

doi:10.3877/cma.j.issn.1673-5250.2007.01.108

Objective

To evaluate the relationship between epidermal growth factor (EGF) and Bcl-2, Bax genetic expression in placenta of fetal growth restriction (FGR).

Methods

25 cases with term normal birth weight and 20 cases with FGR were examined. EGF concentrations in maternal and cord blood were determined by radioimmunoassay (RIA). Bcl-2 and Bax in human placenta were detected by streptavidin peroxidase techniques. Positive cells rate and the ratio of positive area to the total area in single villi were measured by picture analysis system.

Results

Compared to the control group, EGF concentrations of FGR group in both maternal and cord blood decreased significantly (P<0. 01). Bcl-2positive cells rate and the area ratio of positive to villi were both higher in placenta of FGR than that in the normal control group (P < 0. 01). By contrast, Bax both increaded significantly (P<0. 01). In FGR group, there existed positive correlation between EGF concentrations and Bcl-2 expression which included Bcl-2 positive cells rate and the positive area ratio. No relations were observed between EGF and Bax.

Conclusion

The results suggested that reduction of EGF in maternal and cord blood is one of the reason for FGR. Bcl-2 expression is increasing whereas, Bax is decreasing. EGF may inhibit apoptosis in placenta by up-regulating Bcl-2 expression, which may accelerate fetal growth.

Key words: fetal growth retardation, placenta, epidermal growth factor Bcl-2, Bax

图1　 Bcl-2表达呈阳性胞浆胞膜见棕黄色颗粒(IIF×200)

图2　 Bax表达呈阳性胞浆见棕黄色颗粒(IIF×200)

	1　Gupt C. The role epidermal growth factor receptor (EGFR) in mole reproductive tract differentiation：stimulation of EGFR expression and inhibition of Wolffian duct differentiation with Anti-EGFR antibody. Endocrinology, 1996,137:950-910.
	2　Kamei Y，Tsutsumi O, kuwabara Y，et al. Intrauterine growth retardation and fetal losses are caused by epidermal growth factor deficiency in mice. Am J Physiol, 1993，264:597-600.
	3　Bass KE, Morrish D，Roth I，et al. Human cytotrophoblast invasion is up-regulated by epidermal growth factor：Evidence that paracrine factors modify this process. Dev Biol, 1994，164(2)：550-561.
	4　Oltvai ZN，Milliman CL，Korsmeyer SJ. Bcl-2 heterodimerizes in vitro with a conserved homolog，that accelerates programmed cell death. Cell,1993,74(4)：609-619.
	5　Amato D，Zain I，Reed J，et al. Expression of bcl-2 and bax in human placenta. J Soc Gynecol Invest, 1996，3(Suppl) :226.
	6　Smith SC，Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol，1997，177(1)：57.
	7　Smith SC，Baker PN, Symonds EM. Increased placental apoptosisin intrauterine growth restriction. Am J Obstet Gynecol, 1997，177:1395-1401.
	8　Levy R,Smith SD,Chandler K, et al. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol, 2000，278:982-988.
	9　秦晓群，孙秀泓，罗自强.血管活性肠肽、表皮生长因子上调支气管上皮细胞bcl-2基因表达.生理学报，1999，51(4):419-424.
	10　Carcia LMI，Yui J，Winkler LB, et al. Epidermal growth factor inhibits cytokine -induced apoptosis of primary human trphoblasts, J cell Physiol, 1996,167：324-332.

[1]	Yuting Wei, Hong Luo. Current research status of ultrasound elastography on evaluation of fetal growth restriction[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 256-260.
[2]	Danyan Feng, Xiaohui Cao, Yuxia Shi. Effect of serum adiponectin and placental leucine aminopeptidase levels on pregnancy outcome in pregnant women with gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 302-308.
[3]	Defeng Kuang, Zhiguo Li, Shaofang Hua, Fengxia Xue. Levels and significance of fatty acid-binding protein 4 in serum and placental tissues and related lipid protein expression of high-fat-induced pregnant rats[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 338-344.
[4]	Xiaoxiang Wu, Bo Yang, Jingxuan Li, Fengling Zhang, Guihui Guo, Shaopei Zheng. Predictive value of umbilical artery ultrasonography parameters, neutrophil to lymphocyte ratio, and sFlt-1/PLGF ratio for adverse pregnancy outcomes in patients with pregnancy induced hypertension syndrome[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(03): 266-271.
[5]	Zhirong Guo, Jingmei Ma. Risk factors assessment and surgical strategies of placenta accreta spectrum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 151-154.
[6]	Lizi Zhang, Dunjin Chen. Adverse outcomes and longterm prognosis of placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 155-158.
[7]	Shifeng Gu, Lizi Zhang, Jingying Liang, Lili Du, Wen Sun, Dunjin Chen. Hot spots of placenta accreta spectrum disorders research in China from 2011 to 2021: a visualized analysis based on CiteSpace[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 159-166.
[8]	Yongfei Yue, Liping Zhu, Xiaoyan Wang. Evaluation of blood loss by magnetic resonance imaging during cesarean section in placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 167-172.
[9]	Yong Wang, Xialin Li, Rong Yang, Kangni Pan, Lin Yu, Weiwei Wang, Wen Sun, Dunjin Chen. A study of transfusion protocol in placenta accreta complicated with severe postpartum hemorrhage[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 173-179.
[10]	Wenshi Wu, Songquan Wei, Guimin Li, Xiaofang Zheng, Wen Sun, Dunjin Chen, Lin Yu. Outcomes of subsequent pregnancies after partial hysterectomy for placenta accreta spectrum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 180-186.
[11]	Xiaoqin Lu, Xianbao Liu, Shangqian Long, Kexin Song, Yanhong Deng, Chunfang Zhang. Anesthetic decision-making, maternal and neonatal prognosis of cesarean section in patients with different degrees of placenta accreta[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 187-192.
[12]	Xianlan Zhao, Yan Zhou. The interventional radiology of postpartum hemorrhage in placenta accrete spectrum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 147-150.
[13]	Ying Chen, Wanjiang Zeng. The effect and significance of histopathological examination on the placenta accreta spectrum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 143-146.
[14]	Maternal and Fetal Medicine Special Committee of Obstetrics and Gynecology Branch of Chinese Medical Doctor Association;, Critical Care Subgroup, Chinese Society of Perinatal Medicine, Chinese Medical Association. Expert consensus on the use of prophylactic interventional radiology in placenta accrete spectrum diseases[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 133-140.
[15]	Lili Mao, Lin Lin, Xianqin Yin, Wen Sun, Lin Yu, Chunhong Su. Analysis of influencing factors of hysterectomy in patients with placenta previa combined with placenta accrete[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 93-97.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export